Skip to content
★ Sign in to follow
DS

Daniel S. Durrie

Biolase, Inc
Total declarations
11
Company
1
▲ Purchases (9 ops.)
€168k
▼ Sales (0 ops.)
—

Latest filing published 26 Aug 2009 for BIOLASE, INC, €3,266.

Insider track record

Disclosed buys
9
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
9

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Daniel S. Durrie: trading record in brief

Daniel S. Durrie discloses dealings in Biolase, Inc to SEC (Form 4). In total, 11 filings cover trades dated from 15 May 2006 to 25 August 2009.

The open-market record is one-sided, with 9 purchases worth €168k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 option exercises. 2009 to date brings 4 purchases and no sales.

In size, the median ticket on the buying side is €9,659.

The latest filing, published on 26 August 2009, reports an option exercise of €3,266 in Biolase, Inc. The last insider purchase was made public on 26 May 2009, 6,376 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Daniel S. Durrie

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ◇
    DirectorExecutivesBiolase, Inc
    4,650 USD0SEC
    3,750 shares@ US$1.24Common StockSEC:0001209191-09-042141:0
  • ◇
    DirectorExecutivesBiolase, Inc
    3,900 USD0SEC
    5,000 shares@ US$0.78Common StockSEC:0001209191-09-038458:0
  • ▲
    DirectorExecutivesBiolase, Inc
    552 USD0SEC
    460 shares@ US$1.20Common StockSEC:0001209191-09-028647:0
    Canonical exit: 19 Aug 2009 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    3,304 USD0SEC
    2,800 shares@ US$1.18Common StockSEC:0001209191-09-028647:1
    Canonical exit: 19 Aug 2009 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    3,826 USD0SEC
    3,826 shares@ US$1.00Common StockSEC:0001209191-09-026620:0
    Canonical exit: 10 Aug 2009 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    400 USD0SEC
    400 shares@ US$1.00Common StockSEC:0001209191-09-026620:1
    Canonical exit: 11 Aug 2009 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    29,800 USD0SEC
    10,000 shares@ US$2.98Common StockSEC:0001209191-08-029859:0
    Canonical exit: 10 Aug 2008 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    14,950 USD0SEC
    5,000 shares@ US$2.99Common StockSEC:0001209191-08-029859:1
    Canonical exit: 10 Aug 2008 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    64,100 USD0SEC
    10,000 shares@ US$6.41Common StockSEC:0001209191-07-029623:0
    Canonical exit: 8 Aug 2007 (T+90)
  • ▲
    DirectorExecutivesBiolase, Inc
    98,500 USD0SEC
    12,500 shares@ US$7.88Common StockSEC:0001358010-06-000016:0
    Canonical exit: 13 Aug 2006 (T+90)

10 of 10 declarations